Acetaminophen (APAP): Clinical Trials

3 trials of Acetaminophen (APAP), newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 active not recruiting, 1 recruiting, 1 terminated. 2 Phase 4, 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 42Recruiting 1, Terminated 1
Phase 11Active not recruiting 1

Follow Acetaminophen (APAP): new trials by email Literature Review of Acetaminophen (APAP) trials Research Report on Acetaminophen (APAP)

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Evaluating Premedication Regimens (Methylprednisolone vs Dexamethasone-based) for the Prevention of Systemic and Injection Site Reactions to Motixafortide in Patients With Multiple Myeloma Undergoing Stem Cell Mobilization, PARADE Trial
Acetaminophen, Biospecimen Collection, Dexamethasone - Multiple Myeloma
Phase 4RecruitingEmory University942025-09-242026-07-23
A Study to Investigate the Effect of AZD6234, AZD9550, and a Combination of AZD9550 and AZD6234 on Pharmacokinetics of Combined Oral Contraceptive Ethinyl Estradiol/Levonorgestrel in Healthy Female Participants Living With Overweight or Obesity
AZD6234, Ethinyl estradiol/Levonorgestrel (EE/LEVO), Acetaminophen (APAP) - Healthy Participants
Phase 1Active not recruitingAstraZeneca1002025-06-042026-10-13
Multicenter Study to Compare Intravenous and Oral Acetaminophen for the Treatment of Acute Moderate to Severe Pain
IV acetaminophen, Oral acetaminophen, Morphine - Acute Pain, Postoperative
Phase 4TerminatedMallinckrodt12016-04-272019-11-19

Conditions studied

Multiple Myeloma (1)  ·  Obesity (1)  ·  Overweight (1)  ·  Pain, Postoperative (1)

Sponsors

AstraZeneca (1)  ·  Emory University (1)  ·  Mallinckrodt (1)

Countries

United States (3)

Top investigators

Joseph Rimando, MD (1)

NIH funding

P30CA138292 (1)